Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles - Initial evaluation using low molecular weight serum peaks

Proteomics

Volumn 9, Issue 2, 2009, Pages 492-498

  Peng, Jianhe ^a   Stanley, Anthea J ^a   Cairns, David ^a   Selby, Peter J ^a   Banks, Rosamonde E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Coagulation; Proteinchip interface; SELDI; Sequencing; Serum

Indexed keywords

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; EVALUATION; MASS SPECTROMETER; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN MICROARRAY; QUADRUPOLE MASS SPECTROMETRY; SEQUENCE ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ACETYLATION; HUMANS; PEPTIDES; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SEQUENCE ANALYSIS, PROTEIN; SERUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 60349105479     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800424     Document Type: Article

References (23)

1. Ye, B., Skates, S., Mok, S. C., Horick, N. K. et al., Proteomic-based discovery and characterization of glycosylated eosin-ophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin. Cancer Res. 2006, 12, 432-441.
2. Zhang, L., Yu, W., He, T., Yu, J. et al., Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002, 298, 995-1000.
3. Miguet, L., Bogumil, R., Decloquement, P., Herbrecht, R. et al., Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. J. Proteome Res. 2006, 5, 2258-2269.
4. Brown, A. G., Leite, R. S., Engler, A. J., Discher, D. E., Strauss, J. F.III, A hemoglobin fragment found in cervicovaginal fluid from women in labor potentiates the action of agents that promote contraction of smooth muscle cells. Peptides 2006, 27, 1794-1800.
5. Cho, W. C., Yip, T. T., Yip, C., Yip, V. et al., Identification of serum amyloid A protein as a potentially useful biomarkerto monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 2004, 10, 43-52.
6. Zhang, Z., Bast, R. C., Jr., Yu, Y., Li, J. et al., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-5890.
7. Tammen, H., Schulte, I., Hess, R., Menzel, C. et al., Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5, 3414-3422.
8. Zheng, X., Baker, H., Hancock, W. S., Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J. Chromatogr. A 2006, 1120, 173-184.
9. Davis, M. T., Patterson, S. D., Does the serum peptidome reveal hemostatic dysregulation? Ernst Schering Res. Found. Workshop 2007, 61, 23-44.
10. Banks, R. E., Stanley, A. J., Cairns, D. A., Barrett, J. H. et al., Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin. Chem. 2005, 51, 1637-1649.
11. Zhou, M., Prieto, D. A., Lucas, D. A., Chan, K. C. et al., Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2006, 5, 2207-2216.
12. Paizs, B., Suhai, S., Fragmentation pathways of protonated peptides. Mass. Spectrom. Rev. 2005, 24, 508-548.
13. Wattenberg, A., Organ, A. J., Schneider, K., Tyldesley, R. et al., Sequence dependent fragmentation of peptides generated by MALDI quadrupole time-of-flight (MALDI Q-TOF) mass spectrometry and its implications for protein identification. J. Am. Soc. Mass Spectrom. 2002, 13, 772-783.
14. Keough, T., Youngquist, R. S., Lacey, M. P., A method for high-sensitivity peptide sequencing using postsource decay matrix-assisted laser desorption ionization mass spectrometry. Proc. Natl. Acad. Sci. USA 1999, 96, 7131-7136.
15. Lin, S., Tornatore, P., Weinberger, S. R., Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces. Eur. J. Mass Spectrom. 2001, 7, 131-141.
16. Caputo, E., Moharram, R., Martin, B. M., Methods for onchip protein analysis. Anal. Biochem. 2003, 321, 116-124.
17. Noga, M. J., Lewandowski, J. J., Suder, P., Silberring, J., An enhanced method for peptide sequencing by N-terminal derivatization and MS. Proteomics 2005, 5, 4367-4375.
18. Koomen, J. M., Li, D., Xiao, L. C., Liu, T. C. et al., Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 2005, 4, 972-981.
19. West-Norager, M., Kelstrup, C. D., Schou, C., Hogdall, E. V. et al., Unravelling in vitro variables of major importance forthe outcome of mass spectrometry-based serum proteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 847, 30-37.
20. Lopez, M. F., Mikulskis, A., Kuzdzal, S., Golenko, E. et al.,A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clin. Chem. 2007, 53, 1067-1074.
21. Villanueva, J., Martorella, A. J., Lawlor, K., Philip, J. et al., Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol. Cell. Proteomics 2006 5, 1840-1852.
22. Marshall, J., Kupchak, P., Zhu, W., Yantha, J. et al., Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
23. Song, J., Patel, M., Rosenzweig, C. N., Chan-Li, Y. et al., Quantification of fragments of human serum inter-a-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. Clin. Chem. 2006, 52, 1045-1053.